Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion XL for MDD in Women with Breast Cancer
NCT00234195Phase 4Completed
- Sponsor
- Thomas Jefferson University
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bupropion in major depressive disorder (MDD), sponsored by Thomas Jefferson University. Primary endpoints: Efficacy of bupropion extended release and Tolerability of bupropion extended release. Started Sep 2005; status: completed.
02
Drugs
bupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00234195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234195.